Clinical Trials Directory

Trials / Completed

CompletedNCT07325409

Sports Nutrition Benefits of Weizmannia Coagulans BC99

Sports Nutrition Benefits of Weizmannia Coagulans BC99: a Randomized Controlled Trial on Muscle Function and Recovery in Healthy Participants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Wecare Probiotics Co., Ltd. · Industry
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

To evaluate the clinical efficacy of Weizmannia coagulans BC99 in young Chinese patients with exercise-induced muscle damage compared with placebo, and to explore its effects on inflammatory responses and intestinal microbiota.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlaceboThe experimental phase of this study lasts 12 weeks and each participant will have 3 visits (week 0, week 6, week 12)
DIETARY_SUPPLEMENTBC99The experimental phase of this study lasts 12 weeks and each participant will have 3 visits (week 0, week 6, week 12)

Timeline

Start date
2023-11-01
Primary completion
2024-03-10
Completion
2024-03-28
First posted
2026-01-08
Last updated
2026-01-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07325409. Inclusion in this directory is not an endorsement.